Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3351
Gene Symbol: HTR1B
HTR1B
0.020 GeneticVariation disease BEFREE Substance abuse disorder and major depression appear to be associated with the h5-HTR(1B) G861C locus in the patient population, but other psychopathologies such as bipolar disorder, schizophrenia, alcoholism, and suicide attempts were not found to be associated with this polymorphism. 12496953 2003
Entrez Id: 1815
Gene Symbol: DRD4
DRD4
0.060 GeneticVariation disease BEFREE Substance abuse is associated with novelty seeking, a heritable human personality trait which may be influenced by alleles of the dopamine D4 (DRD4) gene exon III VNTR. 9322237 1997
Entrez Id: 627
Gene Symbol: BDNF
BDNF
0.070 Biomarker disease BEFREE Brain-Derived-Neurotrophic-Factor (BDNF) is involved in the neurodevelopment of dopaminergic (DA)-related systems and interacts with the meso-limbic DA systems, involved in the therapeutic response to antipsychotic drugs and substance abuse. 11032392 2000
Entrez Id: 5173
Gene Symbol: PDYN
PDYN
0.020 Biomarker disease BEFREE Prodynorphin (PDYN) is an opioid peptide precursor that yields dynorphins, endogenous kappa opioid-receptor agonists that play important roles in substance abuse. 16529859 2006
Entrez Id: 2562
Gene Symbol: GABRB3
GABRB3
0.010 Biomarker disease BEFREE GABRB3 encoding the β3 subunit of GABAA receptor has been implicated in multiple neuropsychiatric disorders, including substance abuse. 25025424 2014
Entrez Id: 1815
Gene Symbol: DRD4
DRD4
0.060 GeneticVariation disease BEFREE Dopamine D4 receptor VNTR polymorphism associated with greater risk for substance abuse among adolescents with disruptive behavior disorders: Preliminary results. 26688118 2016
Entrez Id: 4986
Gene Symbol: OPRK1
OPRK1
0.040 Biomarker disease BEFREE Kappa-opioid receptor (KOR) antagonists are currently being considered for the treatment of a variety of neuropsychiatric conditions, including depressive, anxiety, and substance abuse disorders. 27699938 2016
Entrez Id: 92737
Gene Symbol: DNER
DNER
0.010 Biomarker disease BEFREE BET proteins have also been shown to be a potential therapeutic target for substance abuse disorders. 27806195 2017
Entrez Id: 627
Gene Symbol: BDNF
BDNF
0.070 Biomarker disease BEFREE Brain-Derived Neurotrophic Factor (BDNF) is implicated in substance abuse disorders including alcoholism. 29158111 2018
Entrez Id: 1268
Gene Symbol: CNR1
CNR1
0.340 Biomarker disease BEFREE Cannabinoid receptor-1 (CB1) represents a potential drug target against conditions that include obesity and substance abuse. 31608546 2020
Entrez Id: 56681
Gene Symbol: SAR1A
SAR1A
0.010 Biomarker disease BEFREE SARA included admissions due to acute or chronic complications of alcohol or drug abuse, as well as substance abuse-related injuries. 31721148 2020
Entrez Id: 9372
Gene Symbol: ZFYVE9
ZFYVE9
0.010 Biomarker disease BEFREE SARA included admissions due to acute or chronic complications of alcohol or drug abuse, as well as substance abuse-related injuries. 31721148 2020
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.400 GeneticVariation disease BEFREE Dopamine D2 receptor gene (DRD2) haplotypes and the defense style questionnaire in substance abuse, Tourette syndrome, and controls. 7647164 1995
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.400 GeneticVariation disease BEFREE A functionally deficient DRD2 variant [Ser311Cys] is not linked to alcoholism and substance abuse. 9650635 1998
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
0.320 Biomarker disease CTD_human A missense mutation in human fatty acid amide hydrolase associated with problem drug use. 12060782 2002
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.340 Biomarker disease BEFREE A polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR) yielding a short (S) and long (L) allele has been associated with severity of substance abuse. 16109588 2005
Entrez Id: 4128
Gene Symbol: MAOA
MAOA
0.020 GeneticVariation disease BEFREE A significant correlation between the presence/absence of the disorder and the length of the MAOCA-1 repeat was found in males, but not females, with "long" alleles (repeat length above 115 bp) associated with both increased risk for the disorder and lower age of onset of substance abuse. 7485245 1995
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.040 GeneticVariation disease BEFREE Allelic variants at the catechol-O-methyltransferase (COMT) locus are candidates to contribute to genetic components of interindividual differences in vulnerability to substance abuse. 9259381 1997
Entrez Id: 1129
Gene Symbol: CHRM2
CHRM2
0.300 Biomarker disease CTD_human Altered neural cholinergic receptor systems in cocaine-addicted subjects. 20393457 2010
Entrez Id: 8936
Gene Symbol: WASF1
WASF1
0.010 Biomarker disease BEFREE Analyses were conducted on respondents who completed Waves 1 and 2 of the National Epidemiologic Survey on Alcohol and Related Conditions and met DSM-IV criteria for substance abuse and dependence prior to but not during the year before the Wave 1 interview (n = 5,515). 28234432 2017
Entrez Id: 4986
Gene Symbol: OPRK1
OPRK1
0.040 Biomarker disease BEFREE Animal pharmacological studies suggest that potent and selective κ opioid receptor antagonists have potential as pharmacotherapies targeting depression, anxiety, and substance abuse (opiates, alcohol, nicotine, cocaine). 30032602 2018
Entrez Id: 1268
Gene Symbol: CNR1
CNR1
0.340 Biomarker disease CTD_human Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential. 21513772 2011
Entrez Id: 6581
Gene Symbol: SLC22A3
SLC22A3
0.300 Biomarker disease CTD_human Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder. 17010131 2006
Entrez Id: 9
Gene Symbol: NAT1
NAT1
0.010 GeneticVariation disease BEFREE Association of the N-acetyltransferase I gene (NATI) with mild and severe substance abuse. 10817597 2000
Entrez Id: 590
Gene Symbol: BCHE
BCHE
0.010 GeneticVariation disease BEFREE Biochemical Analysis and Association of Butyrylcholinesterase SNPs rs3495 and rs1803274 with Substance Abuse Disorder. 30707402 2019